Diabetes drug shows promise in the treatment of non-alcoholic steatohepatitis
A drug approved to treat type 2 diabetes could prove to be a powerful new treatment option for non-alcoholic steatohepatitis (NASH), according to research presented today at The International Liver Congress 2015. Results ...
Apr 23, 2015
0
16